OTC · Medical - Pharmaceuticals

Bloomios, Inc. (BLMS) Stock

$0.00 OTC: BLMS Healthcare

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products.

Valuation

MetricValue
Price$0.00
Market Cap$19341
P/E Ratio—
P/B Ratio—
P/S Ratio0.00
EPS (TTM)$-1.04
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE1400.00%
ROA-53.85%
ROCE353.56%
Gross Margin-66.67%
Operating Margin-66.67%
Net Margin-233.33%
Debt/Equity-22.00
Current Ratio0.07

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$1.0M$8.0M$6.0M
Operating Profit$0$0$-1.0M$-1.0M$-4.0M
Net Profit$0$0$-1.0M$-2.0M$-14.0M
EPS$0.00$0.00$-0.09$-0.16$-1.04
Op Margin——-80.8%-9.4%-68.1%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets—$0$3.0M$4.0M$26.0M
Total Liabilities—$0$4.0M$6.0M$27.0M
Cash—$0$0$0$0
Borrowings$0$0$2.0M$3.0M$22.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$0$0$1.0M$0$-6.0M
Investing Cash Flow$0$0$-5.0M$-2.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$-1.0M$-1.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-2.83
FCF Yield-32831.48%
Quick Ratio0.02
Interest Coverage-0.50
Return 1Y200.00%
Return 3Y-98.32%
Return 5Y—

Ownership

Insiders Held36.31%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIDAAida Pharmaceuticals, Inc. $0.00 — 0.00 $8101 0.00%
ASFXAmerican Scientific Resources, Incorporated $0.00 — — $5251 0.00%
CENBFCEN Biotech, Inc. $0.00 — 0.00 $6526 0.00%
MJNEMJ Holdings, Inc. $0.00 — 0.00 $11654 0.00%
SAGDSouth American Gold Corp. $0.00 — -0.50 $67735 0.00%

About Bloomios, Inc.

Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company’s product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.

Bloomios, Inc. (BLMS) stock trades at $0.00 with a market capitalization of $19341. The stock is valued at price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Bloomios, Inc. generates a return on equity (ROE) of 1400.00% — well above the market average, a sign of a high-quality business, return on capital employed of 353.56%, an operating margin of -66.67%, a net profit margin of -233.33%.

Official website: www.bloomios.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides